Gregory Rinza
Analyst
Truist Securities
Equibles does not estimate personal net worth.
About Gregory Rinza
Gregory Rinza is recorded as Analyst at Truist Securities. Gregory Rinza has spoken on 2 earnings calls across 2 companies, most recently for Revolution Medicines, Inc. on November 4, 2026. Those appearances were for Revolution Medicines, Inc. (RVMD) and Fulcrum Therapeutics, Inc. (FULC). The companies whose calls Gregory Rinza spoke on are classified in the Healthcare sector.
Gregory Rinza on recent calls
“I just wanted to ask on the PD-1-VEGF strategy and perhaps on the partner breadth that you're pursuing. Maybe at first blush, the Bristol collaboration may appear in maybe greater scope than perhaps the Avanesimab combo.”
“And also, let me add my congratulations to Alan on his service at Fulcrum and in the industry.”
Affiliation history
-
Truist Securities
Analyst
Transcript header (unverified)
Current